Association of cytokine gene polymorphisms with hepatitis C virus infection in a population from Rio de Janeiro, Brazil

QR Code

Association of cytokine gene polymorphisms with hepatitis C virus infection in a population from Rio de Janeiro, Brazil

Gustavo Milson Fabrício-Silva,1 Bruno Silva Poschetzky,2 Renata de Mello Perez,2 Ronaldo Carneiro dos Santos,2 Luciana Tricai Cavalini,3 Luís Cristóvão Porto1 1Histocompatibility and Cryopreservation Laboratory, 2Gastroenterology Service, Internal Medicine...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Fabrício-Silva GM, Poschetzky BS, Perez RM, Santos RC, Cavalini LT, Porto LC
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2015
Sujets:	Diseases of the digestive system. Gastroenterology RC799-869
Accès en ligne:	https://doaj.org/article/89fbfec49f0e49aa9bd1a74623af18a6
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Rifaximin in the treatment of hepatic encephalopathy
par: Iadevaia MD, et autres
Publié: (2011)

Epidemiology and treatment of autoimmune hepatitis
par: Francque S, et autres
Publié: (2012)

Hepatitis C in Argentina: epidemiology and treatment
par: Gaite LA, et autres
Publié: (2014)

Transmission, diagnosis, and management of hepatitis E: an update
par: Mirazo S, et autres
Publié: (2014)

Update on entecavir in the management of severe forms of Hepatitis B
par: Sacco R
Publié: (2012)

Reversal of hepatic fibrosis: pathophysiological basis of antifibrotic therapies
par: Ismail MH, et autres
Publié: (2011)

Ending hepatitis C in the United States: the role of screening
par: Coffin PO, et autres
Publié: (2014)

Decline in HAV-associated fulminant hepatic failure and liver transplant in children in Argentina after the introduction of a universal hepatitis A vaccination program
par: Cervio G, et autres
Publié: (2011)

The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia
par: Danish FA, et autres
Publié: (2013)

Overt hepatic encephalopathy in Italy: clinical outcomes and healthcare costs
par: Roggeri DP, et autres
Publié: (2015)

A high prevalence of extreme hyperferritinemia in acute hepatitis patients
par: Kazuhiro Kotoh, et autres
Publié: (2009)

Antiviral therapy for chronic hepatitis B in the indeterminate phase is urgent
par: JIANG Jun
Publié: (2021)

Novel drugs in the management of difficult-to-treat hepatitis C genotypes
par: Cartwright EJ, et autres
Publié: (2013)

Interferon-free combination therapies for the treatment of hepatitis C: current insights
par: Holmes JA, et autres
Publié: (2015)

Hepatitis C infection in Egypt: prevalence, impact and management strategies [Corrigendum]
par: Gomaa A, et autres
Publié: (2017)

Percutaneous hepatic radiofrequency for hepatocellular carcinoma: results and outcome of 46 patients
par: Bertr, et autres
Publié: (2015)

Risk Prediction of Nosocomial and Posthospital Discharge Infections in Alcohol‐Associated Hepatitis
par: Daniel D. Penrice, et autres
Publié: (2021)

A case of hepatic portal venous gas due to viral gastroenteritis
par: Mirmanesh M, et autres
Publié: (2013)

Sofosbuvir for the treatment of chronic hepatitis C: between current evidence and future perspectives
par: Degasperi E, et autres
Publié: (2014)

Clinical features and prognosis of primary myelofibrosis with hepatic vascular disease and/or portal hypertension
par: WANG Jing
Publié: (2021)

Patients in the indeterminate phase of chronic hepatitis B virus infection should be treated
par: JIANG Yingying
Publié: (2021)

Clinical applications of the Model for End-Stage Liver Disease (MELD) in hepatic medicine
par: Lau T, et autres
Publié: (2013)

Association between hepatic fat and subclinical vascular disease burden in the general population
par: Susanne Rospleszcz, et autres
Publié: (2021)

New-onset ascites as a manifestation of virologic relapse in patients with hepatitis C cirrhosis
par: Chua DL, et autres
Publié: (2014)

Critical reappraisal of risk factors for occurrence of hepatocellular carcinoma in patients with hepatitis C virus
par: Bruno S, et autres
Publié: (2011)

Selected biochemical and hematological abnormalities in Nigerians with human immunodeficiency virus and hepatitis C virus coinfection
par: Nwokediuko SC, et autres
Publié: (2011)

Establishment and evaluation of a nomogram for predicting post-hepatectomy complications in two types of hepatic echinococcosis
par: GUO Bing
Publié: (2021)

How far are we from the “Treat all” era of antiviral therapy for chronic hepatitis B
par: DING Yang
Publié: (2021)

Reassessment of the Hispanic Disparity: Hepatic Steatosis Is More Prevalent in Mexican Americans Than Other Hispanics
par: Magda Shaheen, et autres
Publié: (2021)

Pharmacogenetics of hepatitis C: transition from interferon-based therapies to direct-acting antiviral agents
par: Kamal SM
Publié: (2014)

Serum anti-modified citrullinated vimentin antibody concentration is associated with liver fibrosis in patients with chronic hepatitis
par: Suad Abdeen, et autres
Publié: (2011)

Patients with chronic hepatitis B virus infection in the indeterminate phase may benefit from antiviral therapy
par: XU Jinghang
Publié: (2021)

Patients in the indeterminate phase of chronic hepatitis B virus infection should receive active antiviral therapy
par: WANG Jingyue
Publié: (2021)

Leukocyte‐Derived High‐Mobility Group Box 1 Governs Hepatic Immune Responses to Listeria monocytogenes
par: Annika Volmari, et autres
Publié: (2021)

Inhibition of Notch signaling affects hepatic oval cell response in rat model of 2AAF-PH
par: Darwiche H, et autres
Publié: (2011)

Metabolic syndrome in chronic hepatitis C infection: does it still matter in the era of directly acting antiviral therapy?
par: Lim TR
Publié: (2014)

Risk factors for rebleeding after endoscopic selective variceal devascularization in patients with hepatitis B cirrhosis and acute variceal bleeding
par: MA Jiali
Publié: (2021)

Hepatocyte-specific TM6SF2 knockout aggravates hepatic steatosis in mice with nonalcoholic fatty liver disease
par: ZHANG Jie
Publié: (2021)

Persistence of immunity from 1 year of age after one or two doses of hepatitis A vaccine given to children in Argentina
par: Espul C, et autres
Publié: (2012)

Scavenger receptor class B member 1 protein: hepatic regulation and its effects on lipids, reverse cholesterol transport, and atherosclerosis
par: Kent AP, et autres
Publié: (2011)